More about

COVID-19

News
August 24, 2023
2 min read
Save

New-onset inflammatory diseases ‘may be triggered’ by COVID-19 infection, vaccination

New-onset inflammatory diseases ‘may be triggered’ by COVID-19 infection, vaccination

Certain new-onset inflammatory rheumatic diseases, including polymyalgia rheumatica and vasculitis, may be triggered by SARS-CoV-2 infection or vaccination against COVID-19, according to data published in RMD Open.

News
August 24, 2023
2 min read
Save

FDA approves Veklury as first antiviral COVID-19 treatment for all liver disease stages

FDA approves Veklury as first antiviral COVID-19 treatment for all liver disease stages

The FDA expanded its approval of Gilead Sciences’ antiviral, Veklury, for the treatment of COVID-19 in patients with mild, moderate and severe hepatic impairment, without requiring dose adjustments, according to a manufacturer release.

News
August 22, 2023
1 min read
Save

COVID-19 lockdowns may have caused myopic shift in children

COVID-19 lockdowns may have caused myopic shift in children

Mandatory online schooling and confinement during the COVID-19 pandemic may have exacerbated myopia in school-aged children in Puerto Rico, according to a review published in Optometry and Vision Science.

News
August 22, 2023
1 min read
Save

Top in ID: Nose-picking linked to SARS-CoV-2; experts say HIV PrEP should be available OTC

Top in ID: Nose-picking linked to SARS-CoV-2; experts say HIV PrEP should be available OTC

Health care workers who picked their nose were three times as likely to acquire SARS-CoV-2 as those who did not, according to recent study results.

News
August 21, 2023
2 min read
Save

New-onset hypertension more common after COVID-19 than after influenza

New-onset hypertension more common after COVID-19 than after influenza

The incidence of new-onset persistent hypertension is greater in patients with COVID-19 than in those with influenza, researchers reported in Hypertension.

News
August 18, 2023
2 min read
Save

Moderna, Pfizer say updated COVID-19 vaccines protect against EG.5

Moderna, Pfizer say updated COVID-19 vaccines protect against EG.5

Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 viruses and is expected to effectively target them.

News
August 16, 2023
2 min read
Save

Once-daily schizophrenia treatment falls short of endpoints in two phase 3 trials

Once-daily schizophrenia treatment falls short of endpoints in two phase 3 trials

Two phase 3 studies of a once-daily treatment for schizophrenia failed to meet their primary endpoints, with developers pointing to placebo effects and disruption from the COVID-19 pandemic to possibly explain the drug’s performance.

News
August 15, 2023
2 min read
Save

Study of health workers links nose-picking to SARS-CoV-2 infection

Study of health workers links nose-picking to SARS-CoV-2 infection

Health care workers who pick their nose were around three times more likely to become infected with SARS-CoV-2 than those who did not, a small study conducted at two hospitals in the Netherlands found.

News
August 12, 2023
2 min read
Save

Clinicians should consider masking during elevated respiratory viral activity, experts say

Clinicians should consider masking during elevated respiratory viral activity, experts say

Experts said clinicians should consider masking during periods of elevated respiratory viral activity after a study linked pandemic prevention measures to decreases in nosocomial COVID-19 and other respiratory viruses.

News
August 11, 2023
3 min read
Save

EG.5 emerges as dominant variant amid summer wave of COVID-19

EG.5 emerges as dominant variant amid summer wave of COVID-19

The EG.5 omicron subvariant has emerged as the predominant SARS-CoV-2 virus during a summer wave of COVID-19 in the Unted States, accounting for 17.3% of cases, according to CDC tracking.

View more